(ANRG) Anaergia - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA03253E1079
ANRG EPS (Earnings per Share)
ANRG Revenue
ANRG: Waste Processing, Biogas Production, Water Treatment, Residue Management
Anaergia Inc. is a leading provider of innovative solutions for renewable energy generation and waste-to-resource conversion, operating globally across multiple regions including Italy, North America, Europe, the Middle East, Africa, and the Asia Pacific. The companys comprehensive portfolio includes cutting-edge technologies such as OREX, a waste processing solution that extracts and processes organic waste from mixed municipal solid waste, and Omnivore anaerobic digestion, which produces valuable biogas and a nutrient-rich soil amendment byproduct.
The companys diversified business model is structured around three key segments: Capital Sales, Services, and Build, Own, and Operate Projects, enabling Anaergia to capitalize on a wide range of opportunities in the renewable energy and waste management sectors. With a strong presence in the environmental and facilities services industry, Anaergia is well-positioned to benefit from the growing demand for sustainable solutions and the increasing focus on reducing waste and greenhouse gas emissions.
From a technical analysis perspective, Anaergias stock has shown a positive trend, with its 20-day, 50-day, and 200-day simple moving averages (SMA) indicating a gradual upward momentum. The stocks average true range (ATR) of 0.07 represents a 6.06% volatility, suggesting a relatively stable price movement. Given the current price of 1.14 CAD and the 52-week high and low of 1.30 CAD and 0.25 CAD, respectively, we can anticipate a potential price target.
Combining the technical analysis with fundamental data, we can forecast Anaergias stock performance. With a market capitalization of 198.03M CAD and a forward P/E ratio of 8.82, the company appears to be undervalued relative to its growth prospects. The return on equity (RoE) of 89.47% indicates a strong profitability. Based on these factors, we can predict that Anaergias stock price is likely to continue its upward trend, potentially reaching 1.50 CAD in the next 6-12 months, driven by the companys innovative solutions, diversified business model, and growing demand for sustainable energy and waste management services.
Additional Sources for ANRG Stock
ANRG Stock Overview
Market Cap in USD | 174m |
Sector | Industrials |
Industry | Waste Management |
GiC Sub-Industry | Environmental & Facilities Services |
IPO / Inception |
ANRG Stock Ratings
Growth Rating | -46.5 |
Fundamental | -33.4 |
Dividend Rating | 0.0 |
Rel. Strength | 296 |
Analysts | - |
Fair Price Momentum | 1.23 CAD |
Fair Price DCF | - |
ANRG Dividends
Currently no dividends paidANRG Growth Ratios
Growth Correlation 3m | 94.3% |
Growth Correlation 12m | 83.8% |
Growth Correlation 5y | -78.5% |
CAGR 5y | -43.80% |
CAGR/Max DD 5y | -0.44 |
Sharpe Ratio 12m | -0.05 |
Alpha | 360.88 |
Beta | 0.368 |
Volatility | 24.40% |
Current Volume | 18.3k |
Average Volume 20d | 33.4k |
As of June 24, 2025, the stock is trading at CAD 1.38 with a total of 18,301 shares traded.
Over the past week, the price has changed by -2.13%, over one month by +4.55%, over three months by +40.82% and over the past year by +367.80%.
Probably not. Based on ValueRay´s Fundamental Analyses, Anaergia (TO:ANRG) is currently (June 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -33.42 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ANRG is around 1.23 CAD . This means that ANRG is currently overvalued and has a potential downside of -10.87%.
Anaergia has no consensus analysts rating.
According to our own proprietary Forecast Model, ANRG Anaergia will be worth about 1.3 in June 2026. The stock is currently trading at 1.38. This means that the stock has a potential downside of -2.9%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 1.3 | -5.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 1.3 | -2.9% |